Accessibility Menu
Sartorius Aktiengesellschaft logo

Sartorius Aktiengesellschaft(ETR) SRT

Market Cap€13.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)+28,115%
5 Year-70%
1 Year+16%
1 Month-3%
€188.00
-1.05%
-2.00Today
Sartorius Aktiengesellschaft last closing stock price
MetricPriceDate
Last closeEUR 187.202026-08-17
Sartorius Aktiengesellschaft stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.7%EUR 194.402026-08-10
1 month-3.21%EUR 193.402026-07-17
3 month+3.31%EUR 181.202026-05-19
Year to date-1.99%EUR 191.002025-12-30
1 year+16.42%EUR 160.802025-08-15
3 year-34.32%EUR 285.002023-08-18
5 year-69.86%EUR 621.002021-08-18
Since inception+28,115.14%EUR 0.671992-01-02

Sartorius Aktiengesellschaft Financials at a Glance

Market Cap

€13.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€3.58B

Net Income (TTM)

€171.40M

EPS (TTM)

€2.84

P/E Ratio

66.90

Dividend

€0.73

Beta (Volatility)

-0.02 (Low)

Price

€188.00

Volume

3,905

Open

€190.00

Previous Close

€188.00

Daily Range

€182.60 - €190.00

52-Week Range

€154.20 - €208.00

Estimated Earnings Date

Oct 22, 2026

SRT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sartorius Aktiengesellschaft

Sartorius AG, founded in 1870 in Göttingen, Germany, is a leading global supplier of advanced bioprocess solutions and laboratory products. The company serves critical sectors such as life science research and biopharmaceutical manufacturing with a diverse portfolio of innovative products and services.

Products and Services
  • Bioprocess solutions including bioreactor systems and filtration products
  • Laboratory products such as biosensors and cell analysis platforms
  • Comprehensive services for bioprocess development and optimization
Growth Outlook
  • Revenue of €911.8 million in Q2 2026, showing strong demand
  • Trailing twelve months (TTM) revenue growth indicates robust market position
  • Continued investment in R&D supports future product innovation
Financial Highlights
  • Net income of €41.2 million in Q2 2026, reflecting operational efficiency
  • Gross profit margin of 47.5% in Q2 2026, indicating strong profitability
  • Operating cash flow of €175.5 million in Q2 2026, showcasing solid cash generation
Sartorius AG operates in the healthcare sector, focusing on medical instruments and supplies. The company has established itself as a key player in the bioprocessing and laboratory markets, driven by a commitment to innovation and quality. Recent financial performance highlights a strong revenue trajectory, with Q2 2026 revenue reaching €911.8 million, underscoring the company's ability to capitalize on growing demand in the life sciences sector. The gross profit margin of 47.5% reflects effective cost management and pricing strategies, while a net income of €41.2 million demonstrates the company's operational efficiency. Furthermore, the operating cash flow of €175.5 million in the latest quarter indicates robust cash generation capabilities, positioning Sartorius AG favorably for future growth and investment opportunities.
AI Generated • Aug 12, 2026

Industry

Life Sciences Tools and Services

Employees

14,279

CEO

Michael Grosse, PhD

Headquarters

Göttingen, NI 37079, DE

SRT Financials

Key Financial Metrics (TTM)

Gross Margin

45.71%

Operating Margin

17.68%

Net Income Margin

4.79%

Return on Equity

6.28%

Return on Capital

9.32%

Return on Assets

1.79%

Earnings Yield

1.49%

Dividend Yield

0.38%

Payout Ratio

29.64%

Stock Overview

Market Cap

€13.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

69.05M

Volume

3.90K

Avg. Volume

4.09K

Financials (TTM)

Gross Profit

€1.64B

Operating Income

€633.30M

EBITDA

€1.04B

Operating Cash Flow

€734.40M

Capital Expenditure

-€441.50M

Free Cash Flow

€292.90M

Cash & ST Invst.

€306.90M

Total Debt

€4.05B

Sartorius Aktiengesellschaft Performance Analysis

Sartorius Aktiengesellschaft annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 4,174,700,00021.0%
20232023-12-31EUR 3,395,700,000-18.7%
20242024-12-31EUR 3,380,700,000-0.4%
20252025-12-31EUR 3,538,100,0004.7%
Sartorius Aktiengesellschaft sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-4.6%
Q42025-12-3110.0%
Q12026-03-31-3.1%
Q22026-06-301.4%
Sartorius Aktiengesellschaft annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 9.91112.6%
20232023-12-31EUR 3.01-69.7%
20242024-12-31EUR 1.22-59.5%
20252025-12-31EUR 2.2484.2%
Sartorius Aktiengesellschaft sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3034.0%
Q42025-12-31-30.2%
Q12026-03-3184.1%
Q22026-06-3017.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€911.80M

+3.1%

Gross Profit

€433.10M

+4.1%

Gross Margin

47.50%

N/A

Market Cap

€13.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€934.34K

N/A

Employees

14,042

N/A

Net Income

€41.20M

+26.8%

EBITDA

€281.20M

+19.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€306.90M

-64.8%

Total Debt

€4.05B

-13.0%

Accounts Receivable

€381.20M

+21.6%

Inventory

€831.90M

+4.3%

Long Term Debt

€3.65B

-10.8%

Short Term Debt

€403.90M

-28.8%

Return on Assets

1.79%

N/A

Return on Invested Capital

7.76%

N/A

Free Cash Flow

€92.10M

+42.1%

Operating Cash Flow

€175.50M

+16.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,785.76-0.00%
^DJIDJI
$53,732.41-0.00%
^IXICNASDAQ
$26,729.16-0.00%
BTCBitcoin
$63,110.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
IPSTIp Strategy
$8.02+2.65%
SPCXSpace Exploration Technologies
$147.67+0.05%
NOKNokia
$10.93+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.62-0.02%

Questions About SRT

What is the current price of Sartorius Aktiengesellschaft?

Sartorius Aktiengesellschaft is trading at €188.00 per share.

What is the 52-week range for Sartorius Aktiengesellschaft?

Over the past 52 weeks, Sartorius Aktiengesellschaft has traded between €154.20 and €208.00.

How much debt does Sartorius Aktiengesellschaft have?

As of the most recent reporting period, Sartorius Aktiengesellschaft reported total debt of €4.05B.

How much cash does Sartorius Aktiengesellschaft have on hand?

Sartorius Aktiengesellschaft reported €291.00M in cash and cash equivalents in its most recent financial results.

What is Sartorius Aktiengesellschaft’s dividend yield?

Sartorius Aktiengesellschaft currently has a dividend yield of 0.38%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.